Cross-source evidence timeline

Melanotan II research timeline

Follow 17 selected, directly cited source records from April 13, 2006 through March 7, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

17Selected records
7Source years
2Evidence lanes
March 7, 2026Latest source date

Source year

2026

1 record
  1. Literature metadata

    CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.↗

    PubMed lists PMID 35188390 in Journal of medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-21 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

1 record
  1. Literature metadata

    5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.↗

    PubMed lists PMID 38285527 in Chemistry (Weinheim an der Bergstrasse, Germany) as Journal Article, with publication-date metadata of 2024-02-15 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2022

1 record
  1. Literature metadata

    Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.↗

    PubMed lists PMID 34464955 in Dermatology (Basel, Switzerland) as Journal Article, with publication-date metadata of 2021-08-31 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2021

3 records
  1. Literature metadata

    The first preparative solution phase synthesis of melanotan II.↗

    PubMed lists PMID 19043625 in Beilstein journal of organic chemistry as Journal Article, with publication-date metadata of 2008-10-30 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Melanotan II: a possible cause of renal infarction: review of the literature and case report.↗

    PubMed lists PMID 31953620 in CEN case reports as Case Reports, Journal Article, Review, with publication-date metadata of 2020-01-18 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II.↗

    PubMed lists PMID 32674774 in Analytica chimica acta as Journal Article, with publication-date metadata of 2020-05-24 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

8 records
  1. Literature metadata

    Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.↗

    PubMed lists PMID 24771717 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2014-04-25 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.↗

    PubMed lists PMID 11035391 in International journal of impotence research as Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2000-10 (month precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats.↗

    PubMed lists PMID 7981427 in Biopharmaceutics & drug disposition as Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1994-07 (month precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.↗

    PubMed lists PMID 26108334 in Alcoholism, clinical and experimental research as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2015-06-24 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Determination of melanotan II in rabbit urine using solid-phase extraction sample preparation followed by reversed-phase high-performance liquid chromatography.↗

    PubMed lists PMID 9106033 in Journal of chromatography. B, Biomedical sciences and applications as Journal Article, with publication-date metadata of 1997-03-07 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.↗

    PubMed lists PMID 8637402 in Life sciences as Clinical Trial, Clinical Trial, Phase I, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma.↗

    PubMed lists PMID 1336500 in Journal of chromatography as Journal Article, with publication-date metadata of 1992-12-23 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    The unregulated use of melanotan-II is of public health interest to Australian dermatologists.↗

    PubMed lists PMID 28905366 in The Australasian journal of dermatology as Case Reports, Letter, with publication-date metadata of 2017-09-14 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

2 records
  1. Literature metadata

    Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.↗

    PubMed lists PMID 20965250 in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-10-20 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice 2016-27244↗

    The Federal Register published notice 2016-27244, attributed to FDA and its parent HHS department, on 2016-11-14. Its official title is “Edward Manookian (Also Known as Ed Manning): Debarment Order,” and PeptideScanner's exact reviewed identity mapping connects the document to Melanotan II.↗

Source year

2006

1 record
  1. Literature metadata

    Systemic delivery of melanotan II through the ocular route in rabbits.↗

    PubMed lists PMID 9050812 in Journal of pharmaceutical sciences as Letter, with publication-date metadata of 1997-03 (month precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗